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Abstract: 
Coronavirus disease 2019 (COVID-19) pandemic began in December 2019 in Wuhan City China where it is believed 
to have been transmitted to humans from an unknown animal species. The public health, social and economic impact 
of the pandemic world over is detrimental. Health care providers at the frontline in the fight against COVID-19 are at 
the greatest risk of infection and so far, many have been infected and some have already died from the disease. 
Thus, it is imperative that healthcare providers have adequate knowledge of infectious diseases and microbial 
pathogens to comprehend the scale of risk for better recognition and response. Microbiological concepts of infection 
prevention and control, hand hygiene and aseptic techniques are essential in slowing down the spread of the virus. 
COVID-19 has proven that infectious agents can emerge from any region in the world and can spread rapidly with 
ominous consequences to all humanity. This narrative review discusses the role of college-learnt microbiology in 
health care provider preparedness for emerging infectious diseases in light of the current pandemic. 
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Abstrait: 
La pandémie de maladie à coronavirus 2019 (COVID-19) a commencé en décembre 2019 dans la ville de Wuhan en 
Chine, où elle aurait été transmise à l'homme par une espèce animale inconnue. L'impact sanitaire, social et 
économique de la pandémie dans le monde est préjudiciable. Les prestataires de soins de santé en première ligne 
dans la lutte contre le COVID-19 sont les plus exposés au risque d'infection et jusqu'à présent, beaucoup ont été 
infectés et certains sont déjà morts de la maladie. Ainsi, il est impératif que les prestataires de soins de santé aient 
une connaissance adéquate des maladies infectieuses et des agents pathogènes microbiens pour comprendre 
l'ampleur du risque pour une meilleure reconnaissance et une meilleure réponse. Les concepts microbiologiques de 
prévention et de contrôle des infections, d'hygiène des mains et de techniques aseptiques sont essentiels pour ralentir 




la propagation du virus. Le COVID-19 a prouvé que les agents infectieux peuvent émerger de n'importe quelle région 
du monde et se propager rapidement avec des conséquences inquiétantes pour toute l'humanité. Cet examen narratif 
traite du rôle de la microbiologie acquise au collège dans la préparation des fournisseurs de soins de santé aux 
maladies infectieuses émergentes à la lumière de la pandémie actuelle. 
Mots clés: émergent; Les infections; Préparation; Réponse; Microbiologie; COVID-19; Formation 
Introduction: 
 Emerging infectious diseases (EIDs) 
represent significant threats to global public 
health. Frequent outbreaks and epidemics 
continue to occur and exert immense pressure 
on healthcare systems all over the world (1). 
Over 75% of EIDs are zoonotic in nature, 
transmitted by direct contact with animals or 
their products (1). Human-to-animal interaction 
remains the major risk factor, and perceptions 
on the impact of the increasing incidence of 
these infections to the general public and health 
care workers (HCWs) influence the health 
system preparedness and policy interventions 
(2). Emerging infectious pathogens range from 
viruses, bacteria, fungi and protozoa (3). The 
emergence and global spread of antimicrobial 
resistant (AMR) organisms also threatens the 
clinical use of available antimicrobial agents for 
prophylaxis and management of infections (4).  
 COVID-19 pandemic is believed to have 
originated from a sea food market in Wuhan, 
China from an unknown animal source in 
December 2019 when the first case was 
reported. Further investigations revealed that 
the infection was caused by a novel strain of 
beta-coronavirus (CoV) that was subsequently 
named Severe Acute Respiratory Syndrome 
Coronavirus-2 (SARS-COV-2) (5). The disease 
quickly spread from the epicenter and on 
January 15, 2020, the first death was reported 
from Wuhan. Infection among HCWs was 
discovered on January 20, 2020 suggesting 
possible human to human transmission. The 
World Health Organization (WHO) declared the 
outbreak a Public Health Emergency of 
International Concern (PHEIC) on January 30, 
2020 based on the imminent potential of the 
disease to spread internationally (6). Since the 
beginning of the COVID-19 pandemic, the 
impacts on all facets of human life including 
economic, political and social disruptions have 
been catastrophic. The pandemic has evolved 
tremendously and new variants of concern 
(VOC) have emerged in various countries, 
although the impact of the new strains in the 
human population is not yet clear. However, the 
virus has become more adaptive and highly 
virulent with marked transmissibility (7). The UK 
variant of SARS-CoV-2 (VOC 202012/01) for 
instance has been reported in over 80 countries 
prompting the institution of new restrictions and 
lockdowns to curb its spread.   
 At the time of concluding the manuscript 
for this review, the number of confirmed cases 
of COVID-19 globally stood at 130,459,184 with 
2,842,325 cumulative deaths (8). Healthcare 
systems in various countries were ill prepared 
for huge influx of patients with pneumonia 
requiring intensive care services and ventilation 
(9). COVID-19 exhibits severe disease in 
vulnerable individuals who already have various 
underlying conditions that have weakened the 
immune system. This in part coupled with 
accompanying health system constraints (e. g. 
slow diagnostic rollout processes) have resulted 
in high death toll in some countries (10).  
 At the forefront in the fight against the 
pandemic are HCWs, who are mostly doctors, 
nurses, pharmacists, public health experts, 
medical laboratory personnel, medical micro- 
biologists and other responders providing the 
much-needed services. It is indisputable that 
these professionals need a solid knowledge of 
the nature of infectious diseases (e. g. trans- 
mission and pathogenesis) and fundamental 
principles of microbiology, which are essential 
for diagnosis, treatment, management, epide- 
miology, biocontainment and infection preven 
tion and control (IPC) (11). Substantial contents 
of microbial pathogens and infectious diseases 
are entrenched in the respective HCW training 
curriculum, and for non-microbiology majors, 
these courses are usually taught at the pre-
clinical level (12). HCWs need to constantly 
adapt and respond safely to changing infectious 
disease patterns and the unprecedented public 
health emergencies occasioned by COVID-19 
pandemic and other EIDs that may arise in the 
future. 
Overview of emerging infectious 
diseases:  
 An EID is primarily defined as one that 
has existed before but is rapidly increasing in 
incidence or geographic scope or one that has 
newly appeared in the population. Other defini- 
tions include drug resistant pathogens or new 
emerging infections which incidence has increa- 
sed in the last two decades or which incidence is 
likely to increase in the future (3). The definition 
may however vary depending on classifications 
adopted by various experts as a result of the 
complex nature of these infections. Neverthe- 




less, these emerging infectious diseases remain 
a serious threat to global health and security. 
 Over the years, epidemiological and 
geospatial information have demonstrated a 
steady increase in the incidence and geographic 
distribution of emerging pathogens. This pheno- 
menon is thought to be driven mainly by 
socioeconomic, ecological and environmental 
factors. The peak incidence of EID was recorded 
in 1980s associated with the emergence of the 
human immunodeficiency virus (HIV) pandemic 
(13). Previous attempts to understand the 
trends and biology of EIDs have classified viral 
pathogens (particularly RNA viruses) as the 
most significant threat due to lack of a proof-
reading error-correction mechanism in their 
genome replication cycle. As a result, they 
possess higher capacity to acclimatize to new 
hosts including humans (1). One study analyzed 
a database of 355 EIDs between 1940 and 2004 
consisting events caused by newly emergent 
strains of pathogens such as multi drug resistant 
tuberculosis (MDR-TB) and the severe acute 
respiratory syndrome (SARS) coronavirus. The 
report showed that the majority of pathogens 
involved in EID events are bacterial or rickettsial 
(54.3%) due to the emergence of antibacterial 
resistant strains. Viral pathogens or prions 
constituted only 25.4% of the EID events. The 
report further concurred with previous informa- 
tion regarding the incidence of EIDs due to other 
pathogen types which were found to be 10.7% 
for protozoa, 6.3% for fungi and 3.3% for 
helminths (13).    
 Over 75% of EIDs are due to zoonotic 
pathogens transmitted to humans from a non-
human animal species. Wildlife sources have 
previously been implicated in numerous emer- 
gent EIDs, for instance the occurrence of Nipah 
virus in Perak, Malaysia and SARS in China, 
Guangdong Province (14). A number of vectors 
are also responsible for EID events, previous 
estimates reporting EIDs attributed to vector-
borne diseases was put at 22.8% and 28.8% in 
the last decades (13). The beginning and scale 
of an EID is often unpredictable. Many EIDs have 
been identified while many remained to be 
discovered. The HIV/AIDS pandemic has caused 
great human suffering and till the present time, 
there has been no cure for the disease. The 
impacts on the healthcare system globally have 
been detrimental particularly in developing 
countries with limited resources, high population 
growth rate, and poverty. In 2010, the global 
deaths reported were 1.5 million (15). Other 
EIDs identified in the past years include the 
2009 H1N1 influenza, enterovirus 68, hepatitis 
C and E, Bordetella pertussis, poliovirus, and 
rubeola virus (16).    
 Several factors are responsible for the 
emerging and reemerging infectious diseases. 
Primarily, the interface between humans, animal 
and the environment. Human encroachment 
into new environments is one key factor fueling 
exposure to new infectious agents such the 
Ebola Virus Disease in 2014/2015 in West Africa 
(17). Chikungunya and Zika are other examples 
of emerging viruses that have made headlines 
in past few years. Chikungunya, a mosquito-
borne virus which was first reported in 1952, 
recently mutated causing infections in several 
regions mainly Africa, Asia and the Americas 
with more than 1.25 million cases (17). In 2009, 
an emerging fungal pathogen Candida auris was 
identified in a Japanese patient. The organism 
exhibited extreme antifungal resistance and 
caused severe invasive disease among indivi- 
duals with underlying co-morbidities (16).  
 Other factors responsible for the emer- 
gence and re-emergence include changes in 
human social behavior (cultural, sexual and 
war). Increased international travel in particular 
has fueled the spread of such pathogens from 
their source to new environments and vast 
regions which has been a key factor in the 
current COVID-19 pandemic (18). Evolution of 
microbial pathogens, the emergence of anti- 
biotic resistant or antigenic microbial variants, 
intentional release of infectious agents (bio- 
terrorism), lack of political will coupled with 
breakdown of public health systems are other 
key drivers (3). The classic epidemiological triad 
depicted in Fig 1 below explains the interaction 
between microorganism, host and environment, 
which determine disease outcome (19). 
 
 
General features of coronaviruses and 
SARS-COV-2 
 Coronaviruses are enveloped consisting 
of a single stranded positive sense RNA genome 
with up to 32 kilobases. These viruses belong to 




the family Coronaviridae, subfamily Corona- 
virinae in the order Nidovirales according to the 
International Committee on Taxonomy of 
Viruses (ICTV). The viruses are named after the 
arrangement of spike proteins on the envelope 
having a crown like appearance (20). Corona- 
viruses were not considered highly virulent until 
the outbreak of severe acute respiratory syn- 
drome (SARS) in 2002 and 2003 in Guangdong 
Province of China. A highly pathogenic strain 
Middle East respiratory syndrome coronavirus 
(MERS-CoV) appeared later in 2012. It was 
established that direct transmission of SARS-
CoV to humans occurred from market civets. 
Animal contact was consistent in all index cases 
and later discoveries identified SARS-CoV- 
related viruses in horseshoe bats of the genus 
Rhinolophus, suggesting that bats are the 
natural reservoirs of SARS-CoV.  Related strains 
have so far been identified in various regions 
globally including Africa, South East Asia and 
Europe (21). Similarly, the index cases of MERS-
CoV had a history of contact with dromedary 
camels from which direct transmission to 
humans originated. However further investiga- 
tions identified MERS-CoVs in at least 14 species 
of bats from two bat families, Nycteridae and 
Vespertilionidae confirming that camels were 
intermediates (21). Patients infected by MERS-
CoV present with fever and cough, which 
progress to severe pneumonia and in some 
cases diarrhea is the first symptom to appear 
following an incubation of up to 14 days (17). 
Similar to the COVID-19 pandemic caused 
SARS-CoV-2, MERS-CoV causes severe disease 
in individuals with weak immunity and those 
with underlying conditions such as diabetes and 
chronic lung disease. 
 Severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) is a beta-corona- 
virus that was initially named novel coronavirus- 
2019 (nCoV-2019). The virus is responsible for 
the worst global pandemic in the current 
civilization.  The disease began in Wuhan, Hubei 
Province, China, around December 2019 where 
the first cases of flu-like disease with pneumonia 
of unknown aetiology were reported (22). The 
likely source of the infections was traced to 
Huanan seafood market where it was believed 
to have been transmitted to human from an 
animal species. The virus primarily targets the 
respiratory system leading to complication of 
acute respiratory distress syndrome (ARDS). 
Patients with COVID-19 have shown abnormal 
respiratory symptoms such as pneumonia, 
ground glass opacities and cardiac injury as well 
as increased leukocyte counts and pro-inflam- 
matory cytokines which promote disease seve- 
rity (10).     
 COVID-19 has exhibited unique features 
particularly with the possibility of asymptomatic 
individuals to transmit the virus before any 
symptom becomes apparent. The virus is also 
highly transmissible with some studies reporting 
an average basic reproductive number (Ro) of 
3.28 and a median of 2.79 (23). The new virus  
variants of concern (VOC) present a more com- 
plex scenario with the UK variant for instance 
exhibiting a 43–90% (95% CI 38–130) higher 
reproduction number (7). Globally, the number 
of cases and deaths are increasing and as of 4th 
April 2021, over 4 million new cases were 
reported in a week, with 11% increase in morta- 








Fig 2: Schematic representation of coronavirus                
Source: https://viralzone.expasy.org/764?outline=all_by_species 
Consequences of emerging and re-
emerging infectious diseases on 
healthcare workers (HCWs) 
 Emerging infectious agents such as the 
SARS-CoV-2, MERS-CoV, Ebola virus and multi- 
drug resistant (MDR) organisms exhibit high 
virulence in humans. This is mainly due to well 
adapted pathogen virulence factors and lack of 
immunity in the population. The COVID-19 pan- 
demic has had its greatest impact on frontline 
healthcare workers ever witnessed in the recent 
years. As of March 2020, there were 3300 
infections of HCWs in China and by February at 
least 22 HCWs had died. In Italy, over 20% of 
HCWs responding to the pandemic have acqui- 
red the infection and some had died (5). The 
trend is the same in other regions across the 
world and keeping HCWs safe is now a top 
priority for most governments. In part this has 
been attributed to shortages of personal 
protective equipment (PPE) such as aprons, 
gloves, medical masks, goggles, respirators, 
gowns and face shields. The shortage has been 
occasioned by the high-rate consumption due to 
huge influx of COVID-19 patients to healthcare 
settings increasing exposure rates for HCWs. 




The WHO estimated through modeling that 89 
million medical masks and 76 million examina- 
tion gloves are needed for COVID-19 response 
each month with international demand for 
goggles standing at 1.6 million per month (24, 
25).      
 During the outbreak of Ebola Virus 
Disease (EVD) in 2014-2015, many HCWs were 
infected and the WHO reported 874 cases of EVD 
with 509 deaths among HCWs in West Africa 
(26). A systematic review including 94 articles 
linked to 22 outbreaks exploring the infection 
rates and associated risk factors for infection 
among HCWs during Ebola and Marburg virus 
outbreaks highlighted inadequate and inappro- 
priate use of PPEs and exposure to individuals 
with asymptomatic Ebola and Marburg infection 
(27). The highest of HCWs exposed were nurses 
(61%) and medical staff, hence over half of the 
cases were in this occupation. A similar trend 
has been observed in China where approxi- 
mately 60% and 30% of HCWs infected were 
nurses and clinical personnel (28). However, 
with continued integration of healthcare services 
and patient management in healthcare delivery, 
there is an increased risk to other occupations 
which should be considered in infection 
prevention and control (IPC) efforts (27). With 
the emergence of new pathogens such as the 
current COVID-19 pandemic, lessons learnt 
from previous outbreaks should be implemented 
appropriately and best practices adopted to 
reduce the impact on health care works and the 
entire population.     
 Some of the important measures imple- 
mented in the current COVID-19 pandemic 
include social distancing, hand hygiene, HCW 
training on IPC and supply of adequate PPEs. 
Many countries have also implemented lock- 
downs to restrict movement and human interac- 
tions as well as cancellation of international 
travels and extensive screening at entry points. 
As new infections emerge, there is a greater 
need for sufficiently trained IPC specialists for 
proper response to these extraordinary events 
(29).      
 The impact of EIDS to countries and the 
global community are enormous as witnessed in 
the current COVID-19 pandemic. Therefore, 
every country should prepare and build the 
necessary capacity and infrastructure in disease 
surveillance, diagnostics, education, training, 
research, communication and strategic planning 
to be able to quickly recognize and respond 
adequately to any such events (30). Prompt and 
well-structured response limits the overall 
mortality and morbidity as well as economic 
implications. Newly EIDS often compete with 
other healthcare priorities and existing diseases 
hence vital resources in the healthcare system 
are overstretched (2). The extensive systematic 
review highlighted the risk factors associated 
with HCW infections during Ebola and Marburg 
outbreaks. Key among them was insufficient and 
inappropriate use of PPEs, lack of training in PPE 
and hand hygiene, multiple use of disposable 
PPEs and HCW refusing PPEs while caring for 
patients. Other important factors included inap- 
propriate risk assessment and lack of environ- 
mental controls  (27). 
Significance of basic microbiology 
training on infection control practices 
by healthcare providers 
 Medical microbiology is a subject of 
medicine concerned with the study of human 
infectious diseases and responses to such 
infections. The main focus includes aetiology, 
pathogenesis, laboratory diagnosis, treatment, 
epidemiology and infection control. The subject 
is generally taught as a pre-requisite basic 
science in medical, nursing, public health, 
clinical medicine and other relevant paramedical 
courses. The subject is meant to equip learners 
with the knowledge of medically important 
microorganisms such as bacteria, viruses, 
protozoa, fungi and other infectious agents. The 
pre-clinical curricular for non-microbiology 
courses (nurses, doctors and public health) 
covers most of the infectious diseases. However, 
there is a continuously expanding content in this 
subject as new infectious agents emerge and 
more discoveries are made on the existing 
organisms (31). Some of the most important 
areas of concern to medical practice currently 
include IPC, antimicrobial resistance (AMR), 
EIDs, and global health, which are supposed to 
be taught along with the foundational micro- 
biology course (32). In this regard, there is a 
greater need for adaptability in the teaching and 
training as well as medical microbiology content 
evaluation from time to time.   
 In recent years, there has been a surge 
in the frequency of healthcare associated infec- 
tions which has greatly impacted patient care as 
well as HCWs. Healthcare associated infections 
(HAIs) are mainly caused by highly resistant 
microorganisms such as methicillin-resistant 
Staphylococcus aureus (MRSA) and multi-drug 
resistant tuberculosis (MDR-TB). The microbes 
colonize the hospital environment and the cycle 
of transmission and outbreaks can occur for an 
extensive period of time. The sources are either 
endogenous (from the patient’s own flora) or 
exogenous (from healthcare worker's hands) 
(33). Prevention of HAIs is now considered part 
of safe and quality healthcare delivery which has 




created new demands in the health care system 
with significant cost implications when imple- 
menting enhanced IPC measures and the 
resulting longer hospital stays for infected indi- 
viduals (34). Occurrence of HAIs may also have 
judicial consequences for responsible health 
facilities (35). It is estimated that 10% of 
hospitalized patients in the developed countries 
will develop a HAI while the risk in developing 
countries is 2-20 times more (33). EIDs such as 
COVID-19 (SARS-CoV-2 infection) are often 
noticed when HCWs have already been infected 
and other patients within the healthcare setting 
are always at risk.    
 In view of the emerging complexities 
regarding infectious diseases, it is crucial that 
HCWs involved in patient care possess sufficient 
IPC knowledge and skills in order to address 
these challenges in a safe manner. Basic micro- 
biology training should empower medical 
students to understand the nature of infectious 
diseases (e. g. transmission, pathogenesis and 
diagnosis) and the risk level for adoption of 
proper IPC measures in their future clinical 
practice. The relevant topics include appropriate 
use of antibiotics, safe collection of specimen for 
microbial analysis, preparation of specimens for 
shipment and delivery, communicating micro- 
biological results to patients and healthcare 
teams, and appropriate care for patients based 
on microbiological results and their immune 
status (36).   
 Regarding IPC, the most vital concepts 
include use of PPEs, hand hygiene, handling and 
safe disposal of sharps, aseptic techniques, 
clean clinical environment and decontamination 
(37). A number of studies have highlighted 
challenges in IPC compliance among nurses and 
clinicians. One online survey sought to evaluate 
the experience of student nurses in clinical 
placement where they were presented with a 
range of questions as to whether they had 
witnessed some lapses in IPC and the frequency 
of such lapses. All participants reported to have 
witnessed lack of compliance particularly for 
hand hygiene and over 75% reporting failure to 
clean hands between patients contact. Other 
lapses were witnessed in isolation precautions, 
poor cleaning of patient environment, changing 
of PPE between patients, and improper handling 
of sharp instruments (38). Another study that 
sought to evaluate the effectiveness of a special 
IPC training offered to nursing students before 
graduation reported a positive influence of the 
program on the students IPC knowledge, 
attitudes and compliance. The study used an 
experimental design where participants were 
randomly assigned to two groups with pre and 
post-tests which demonstrated the importance 
of such programs in supplementing basic 
curricula training (37). It has been demons- 
trated that nursing students have a positive 
attitude towards hand hygiene and IPC signi- 
fying their concern for safety and patient care. 
 Infection prevention and control is 
deeply anchored in a thorough understanding of 
microbiological principles, particularly pathogen 
characteristics (transmission and pathogenesis).  
Therefore, IPC decisions should be based on 
these factors. It has been shown that HCWs 
often make decisions regarding IPC based on 
their perceived (often inaccurate) judgment of 
risk rather than rational application of micro- 
biological principles (39). Therefore, failure to 
correctly assess the risk may compromise safety 
of the HCWs. Some reasons for the significantly 
high HCWs infections in the COVID-19 pandemic 
apart from the shortage of PPEs include lack of 
understanding of the pathogen, poor knowledge 
of IPC, exposure to a large number of infected 
patients for a long period of time, work intensity, 
lack of rest and pressure, lack of training on IPC 
for respiratory borne pathogens and lack of pro- 
fessional supervision and guidance on the pan- 
demic response (28). These factors contributed 
to substantial HCWs exposure and infections at 
the onset of the outbreak.  
 Infectious agents are generally catego- 
rized into four biosafety levels which determine 
the level of containment and safety precautions 
needed when handling them. One factor that 
influences the adoption and compliance to IPC 
precautions has been explained through the 
Health Believe Model (HBM), a theory developed 
to explain health related behaviors. The HBM 
suggests that the likelihood of an individual to 
engage in a health related behavior is deter- 
mined by their perception of four important 
variables; susceptibility, severity, benefit and 
barriers (40). Threat perception is based on two 
beliefs; perceived susceptibility of the individual 
to a certain disease and the perceived severity 
of the disease to the individual. Based on this 
concept, there is need to influence behavior 
change and health beliefs of HCWs to enhance 
the adoption of safe practices (41).  
 
Strengthening medical microbiology in 
academic medical training institutions  
 The discovery of microorganisms in the 
17th century by Robert Hooke and Antoine van 
Leeuwenhoek due to their interest in micro- 
scopes laid the foundation for today’s technolo- 
gical advancements in microbial studies (42). 
The world over, medical training institutions are 
the epitome of knowledge that can be leveraged 
to develop vital remedies in times of public 




health emergencies. As the pandemic rages, a 
number of vaccines have been developed and 
universities such Oxford in the UK have played 
a key role in this endeavor. Despite the develo- 
pment and rollout of COVID-19 vaccines, cons- 
traints still exist particularly the availability of 
enough doses for the entire population as well 
variants of concern (VOC) that could impact on 
the efficacy of the existing vaccines. Continuous 
research on the virology of SARS-CoV-2 is 
paramount for better control strategies. One 
significant milestone was the successful 
genomic sequencing of the virus which enabled 
further informed experiments for vaccine 
development (5).    
 Academic medical institutions are man- 
dated to train competent healthcare personnel 
who can diligently serve in the community. 
Medical students are future HCWs and as such, 
sufficient training to inculcate sound knowledge 
of medical microbiology and IPC competency is 
indispensable. To facilitate compliance with set 
safety precautions among nursing students, it 
has been proposed that IPC competence should 
entail theoretical, practical, and decision-
making competence (39). Based on this pro- 
posed approach, students would need to 
understand, analyze, synthesize, and apply the 
knowledge of microbiology. The decision-
making competence would be essential for 
effective response in the event of an emerging 
infectious agent such as the current SARS-CoV-
2, MERS-CoV or Ebola virus which requires an 
in-depth understanding of microorganisms (e. g. 
mode transmission and portals of entry) rather 
than simple memorization of procedures. 
Another approach is the provision of additional 
microbiology classes and special programs 
focusing on important IPC concepts. Data have 
shown that adequate understanding of IPC and 
consequences of breach among HCWs improves 
the overall compliance (43).   
 To be able to recognize and respond 
adequately to future emerging and re-emerging 
infectious diseases, and to address the rising 
challenge of AMR, medical students should be 
exposed to these important concepts early in 
their career. The concept of “One Health” is 
critical considering that the majority (>70%) of 
EIDs are zoonotic and mainly related to wild 
animals (44). Medical students need to have 
understandings of the interface between human, 
animal, and environmental health. This will 
promote future interactive multidisciplinary 
efforts both locally and internationally to 
address AMR and zoonotic diseases (2,45). 
Medical students, nurses and clinicians should 
be given opportunities to participate in 
multidisciplinary teams involved in community 
and patient education on “One Health” to 
promote better understandings and real-life 
applications. This can be augmented by mentor- 
ship programs to stimulate interests in this 
important subject.    
 Antimicrobial stewardship (AMS) has 
been embraced as the means to address the 
rapidly emerging resistance to antimicrobials 
and to promote accountability and rational use 
of these medicines which are vital global 
resources that need to be safeguarded (46,47). 
One of the key challenges to this initiative that 
has been highlighted include communication 
barriers between microbiology laboratories and 
other care units within health settings. In 
essence, the clinicians and the nursing staff 
have had challenges interpreting some of the 
microbiology reports while the laboratory could 
miss vital information in request forms mainly 
due to the lack of in-depth knowledge into each 
other’s areas of expertise (48). This impediment 
could be addressed by equipping medical 
students with knowledge of various aspects of 
such initiatives for effective communication and 
implementation later in clinical practice. This will 
also enhance accurate patient management and 
timely notification of unusual infectious disease 
diagnosis and resistant strains.   
 As a public health endeavor, medical 
students should also be equipped with adequate 
knowledge of infectious disease epidemiology 
and sensitized on reporting of notifiable infec- 
tious agents. This will empower them to capture 
quality data (such as person time relationship) 
that can be synthesized to generate vital 
inferences to trace EIDs and implement timely 
response decisions to prevent escalation of such 
unusual events. Essentially this will ultimately 
contribute to international surveillance of EIDs 
and epidemic intelligence (49). 
 Currently, there is extensive automation 
of microbiology and sophisticated analytic plat- 
forms for diagnosis and research on infectious 
diseases. Therefore, medical students should be 
kept abreast with the progress so far as new 
instruments are introduced in routine diag- 
nostics and patient care. Most significantly is the 
utility of molecular tests in diagnosis and 
treatment monitoring. One such platform is the 
GeneXpert, a cartridge based molecular assay 
which was developed for rapid detection of 
Mycobacterium tuberculosis and resistance to 
rifampicin (50). This technology has also been 
explored for the diagnosis of current COVID-19 
pandemic and was granted emergency use 
authorization (EUA) approval by the US Food 
and Drug Admiration (FDA) on March 22, 2020 
(51).     
 Innovative pedagogical approaches are 




also critical in delivery of medical microbiology, 
which can be adopted for concepts such as EIDs 
and AMS (46). There have been important 
developments in current education practice 
mainly geared towards excellence in teaching 
and professional development (52). One impor- 
tant concept is the application of a flipped 
classroom (FC) approach where students are 
first exposed to the learning materials which 
may be readily available online or shared by the 
instructor. Thereafter, time is dedicated where 
learners are engaged in student-centered activi- 
ties that encourage active learning. This method 
has gained acceptance since it promotes the 
development of  life-long skills  for self-directed 
learning among medical students (53). Other 
approaches include adoption of technology and 
online teaching platforms which could facilitate 
sufficient course coverage and are equally 
engaging and interactive (54,55). Periodic 
curriculum reviews are also vital to incorporate 
new developments in medical microbiology 
relevant to healthcare delivery. 
Conclusion: 
 Emerging infectious diseases remain the 
greatest threat to international public health and 
the global economy. The current COVID-19 pan- 
demic is causing untold human suffering with 
significant fear and mortality. HCWs all over the 
world are at the greatest risk of infection and 
the number infected globally is alarming while 
some have died. There are number of reasons 
for these which include among others, shortage 
of PPEs, inadequate training on IPC and extreme 
work intensity. Consequently, governments of 
countries have undertaken drastic measures to 
ensure adequate PPE supplies, training and re-
training of HCWs and most importantly prioriti- 
zation of HCWs in vaccine rollout.  
 To address these challenges now and in 
the future, there is need to strengthen founda- 
tional microbiology and IPC concepts during 
college training. Furthermore, health students 
should be encouraged to develop positive health 
beliefs to promote adoption and implementation 
of safe healthcare delivery practices later in their 
careers. To address the concerns of EIDs, 
sufficient infectious disease experts should be 
trained and international collaboration fostered. 
EIDs are primarily zoonotic and therefore patho- 
gen surveillance in both domestic and wild 
animals should be heightened. It is now evident 
that infectious agents can emerge from any 
region across the world and as such affluent 
nations should invest and support countries with 
limited diagnostic and surveillance capacity to 
be able to detect and control such pathogens 
early. This will in future serve to avert the wide- 
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